Noora (vaccine)
Noora () is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv Sepid Co. (lit. White Cypress Plasma Treatment) in Iran. Medical uses 
It requires three doses given by intramuscular injection on days 0, 21 and 35. Pharmacology 
Noora is a recombinant RBD protein subunit vaccine. Manufacturing 
Up to 8 December 2021, 5 millions doses have been produced. Clinical trials

See also 
 Pharmaceuticals in Iran
 COVID-19 pandemic in Iran
 COVID-19 vaccine clinical research

References 

Iranian COVID-19 vaccines
Science and technology in Iran
Protein subunit vaccines